Healthcare DIVE September 25, 2018
Samantha Liss

Dive Brief:

  • CVS’ CEO and CFO laid out examples for how consumers and shareholders could benefit from the proposed merger with Aetna during a recent investor meeting hosted by Mizuho Securities. Mizuho analysts said investors have been interested in the “long-term merits” of the deal, which is expected to achieve $750 million in cost savings in the second full year after closing.
  • Executives described how they could use its existing services to better serve Aetna’s members. As soon as the deal closes, if it does, CVS believes it will have immediate access to 20% of Aetna’s membership currently using the stores. That matters because CVS believes its pharmacists play a crucial role in shaping a patient’s overall behavior....

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Insurance, Mergers & Acquisitions / JV, Payer, Pharma, Provider, Retail care, Trends
Halozyme abandons its €2bn pursuit of Evotec
M&A Cyber Success Depends on Communication, an Honest Evaluation of Each Side’s Strengths & Risks, and an Open Mind
Halozyme Pulls €2B Acquisition Bid as Evotec Commits to Standalone Strategy
Concerns raised over Indiana hospital merger
Medtronic buys surgical instrument developer Fortimedix

Share This Article